VentriPoint Diagnostics (TSE:VPT) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Ventripoint Diagnostics Ltd. is extending its offering of unsecured convertible debentures, with a second closing imminent and finalization expected by July 26, 2024. The debentures, issued at $1,000 each, have a conversion rate into common shares at $0.25 and yield a 10% annual interest, payable semi-annually. An automatic conversion feature is triggered if the company’s stock price exceeds $0.50 for five consecutive days before October 20, 2026, at which point holders also receive warrants to buy additional shares at $0.70 each.
For further insights into TSE:VPT stock, check out TipRanks’ Stock Analysis page.